Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy. - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.

http://www.wikidata.org/entity/Q37639909

about

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.

http://www.wikidata.org/entity/Q37639909

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics of ...... ous renal replacement therapy.

@en

Population pharmacokinetics of ...... ous renal replacement therapy.

@nl

type

label

Population pharmacokinetics of ...... ous renal replacement therapy.

@en

Population pharmacokinetics of ...... ous renal replacement therapy.

@nl

prefLabel

Population pharmacokinetics of ...... ous renal replacement therapy.

@en

Population pharmacokinetics of ...... ous renal replacement therapy.

@nl

P1433

Q37639909-6C40FBE9-8558-4BC1-A0F2-FA95088BDA17

P1476

Q37639909-D5EA74C5-27F1-4BBF-AD73-13C78D96CF09

P2093

Q37639909-5168B29F-ACA8-4DAF-BDD3-0E430D4712C2

Q37639909-555C36DD-FD51-49CE-9714-3233404CFF1B

Q37639909-6348E992-7DCC-4002-AF71-9CCD2C2B0C1D

Q37639909-AFDE8DEB-F46A-4B05-A550-79382C40657C

Q37639909-FF057D25-4106-45C3-84DF-A52C23DC6DB9

P2860

Q37639909-0657D7EF-EC21-424B-B72F-523F66C8D76E

Q37639909-0B9429D5-E97C-4E6B-81F1-801C6EC7FB2F

Q37639909-1854DB64-42E5-406E-AFD8-D92B42C1CF31

Q37639909-2038F9F0-7D15-44DE-980A-FD22BF8D1912

Q37639909-251FB99B-6C3B-4FFB-A023-2819D1D45481

Q37639909-3D3FA359-9FD9-4B3D-8176-C844FFA14B34

Q37639909-3F5638F0-AEA4-4882-9F92-092B6B191E64

Q37639909-41664619-2B1C-4AFB-8C3F-9B6DB3FBAE4B

Q37639909-417832C7-7316-4769-AA56-92FC2185208F

Q37639909-533EB285-5EE9-4C28-8B3D-9A7DFA561703

P304

Q37639909-14612CF3-9F63-49F0-B86B-2345A2D5055E

P31

Q37639909-2C4F9787-FC51-4FCB-B030-A2E942CD3D89

P356

Q37639909-9538EC8D-6746-496B-8B8B-C80C448C297C

P407

Q37639909-43F31596-EABF-46C5-8636-34CC518B1BEE

P433

Q37639909-6A12F184-E62A-48FB-A4F5-D7C5A6325B37

P478

Q37639909-42FC6769-46A2-44AA-989E-57F4133436C7

P50

Q37639909-073B9AFA-9946-4815-A00A-83168BBC11B4

Q37639909-730BE2E1-7CE3-4B16-9E64-61EED5999E25

P577

Q37639909-090806D1-0574-4376-83CF-2696AB0E47C2

P698

Q37639909-DC2F783E-6B40-4B21-8A41-7F80AB7564BC

P932

Q37639909-099982FC-3A6F-439C-9759-3CBE730CD106

P356

P1433

British Journal of Clinical Pharmacology

P1476

Population pharmacokinetics of ...... ous renal replacement therapy.

@en

P2093

Dmytro Khadzhynov

http://www.w3.org/2001/XMLSchema#string

Micha Levi

http://www.w3.org/2001/XMLSchema#string

Natascia Corti

http://www.w3.org/2001/XMLSchema#string

Ricardo L Chaves

http://www.w3.org/2001/XMLSchema#string

Xiaoying Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

Bacterial biofilms: from the natural environment to infectious diseases

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.

In vivo pharmacodynamic activity of daptomycin

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

Renal replacement therapy in the intensive care unit.

P304

498-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13131

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27628437

http://www.w3.org/2001/XMLSchema#string

P932

5306496

http://www.w3.org/2001/XMLSchema#string